Skip to content

FDA

A Family’s Journey from Asthma to Depression to Advocacy

Posts Tagged ‘FDA’

A Family’s Journey from Asthma to Depression to Advocacy

Laura Marotta was just trying to treat her son’s asthma. Instead, the asthma medication led to extreme adverse side effects, including depression, anxiety, and hallucinations. My Gene Counsel’s President and CEO, Ellen Matloff, had the opportunity to talk to Laura and her son, Nicholas, about their journey from asthma to depression to finally finding their way…

Read More

My Gene Counsel Releases New Reports on 23andMe Findings

My Gene Counsel, a digital health company that provides personalized, easy-to-understand web-based genetic counseling, today announced that the company has expanded its database of genetic resources to include content for at-home genetic tests related to MUTYH-associated polyposis (MAP), familial hypercholesterolemia (FH), and Parkinson’s disease.

Read More

21st Century Cures Act Passes House of Representative

On July 10, 2015 the House of Representatives approved the 21st Century Cures Act (H.R. 6) with a vote of 344-77. This act will launch healthcare into the 21st century by “investing in science and medical innovation, incorporating the patient perspective, and modernizing clinical trials, to deliver better, faster cures to more patients and loved…

Read More

Has the BRCA Monopoly Been Reborn?

A controversy has been brewing under the surface for several months in the genetic testing world. Namely, will BRCA carriers with ovarian cancer be forced to undergo BRCA testing a second time – at >$4000 a pop – in order to qualify for a new drug called Olaparib. Why? The FDA has approved PARP-inhibitor Olaparib for…

Read More

Video: Reflections on DTC genetic testing one year after FDA shutdown

One year ago today, the FDA made a very controversial decision to shut down the biggest direct-to-consumer (DTC) genetic testing company out there. On the anniversary of that decision, our President and CEO Ellen T. Matloff, reflects on the issues surrounding DTC genetic testing and explains why the big question is not whether or not there…

Read More